NCOA3 and breast cancer: It has been demonstrated that high expression of steroid receptor coactivator 3 (SRC-3), known to play a critical role in mammary tumor development and metastasis (36, 37), is correlated with poor survival in ER-positive breast cancer patients (38, 39).